VivoSeq
Other

Tooth Sensitivity

0

Pipeline Programs

1

Active Trials

1

Companies Involved

Tooth Sensitivity is an early-stage landscape with 0 programs across 1 company. The most active players are Johnson & Johnson Consumer and Personal Products Worldwide.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

13

clinical trials

Completed11 · 85%
Unknown status1 · 8%
Not yet recruiting1 · 8%

Trial Activity

13 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)